Cancer Research Institute

This #ColorectalCancerAwarenessMonth, Gordon, a stage 4 colorectal cancer survivor, has a simple message to share- stop avoiding the conversation- and get screened. Learn more: bit.ly/4snQTd7 #CRC #ColorectalCancer

From pioneering discoveries, to modern breakthroughs, and fierce advocacy, the 8 women highlighted by CRI for #WomensHistoryMonth have reshaped the landscape of science and medicine. Meet these trailblazers: bit.ly/4slFLOi #WHM #CancerResearch #Immunotherapy

🧡 Thank you @CancerResearch for featuring one of our advisors Peggy Zuckerman - an astounding patient advocate for decades - during #KidneyCancerAwarenessMonth!

👏 Through the dedication of the Landesman family and the generosity of the Sailfish Point community, the 14th annual Keith A. Landesman Fundraiser raised more than $330,000 to support early-career scientists working to advance cancer immunotherapy! More: bit.ly/3PcCwtS

Did you know? Clinical trials aren’t just for people who have “run out of options.” Many clinical trials test therapies already approved by the @US_FDA in new combinations or during earlier stages of treatment. Learn more: bit.ly/45CvWkR #CancerResearch #ClinicalTrial

DYK? Colorectal Cancer is now the leading cause of cancer-related death among young adults. Explore the causes, understand the risk factors, and review prevention tips, during March's #ColorectalCancerAwarenessMonth: bit.ly/47nT7lq #CRC #CancerResearch

DYK? Colorectal cancer is often preventable, and highly treatable when detected early. Screening guidelines generally recommend beginning regular screening at age 45. Get more info during Colorectal Cancer Awareness Month: bit.ly/47nT7lq #CRC #ColorectalCancer

Investigators @UTSWMedCenter including CRI Lloyd J. Old STAR Dr. Tuoqi Wu discovered that increasing the levels of a protein called BACH2 makes engineered cancer-fighting immune cells behave more like stem cells, improving their therapeutic effectiveness: bit.ly/45r0iYj

⚡ When Peggy was diagnosed with stage 4 kidney cancer, she refused to let confusion define her experience. After #immunotherapy eliminated her tumors, she found a new purpose: helping other patients understand their disease and speak up for themselves: bit.ly/4bARfYc

The #IO360Summit showcased decade-long survival data, next-gen therapies, and AI applications, highlighting how far the field has progressed, and where it may be headed next. Review CRI's key takeaways from the three-day long event, in our new blog: bit.ly/4cxFB1h

Supporting science at the intersection of aging biology + cancer, @TheMarkFdn @WaxmanCancer announced $2.5M to take aim at the leading risk factor for cancer: aging. This initiative brings together a multi-org partnership including @AmericanCancer and CRI: bit.ly/3ZpVvD8

Ongoing kidney cancer research focuses on improving survival, especially among more advanced patients, and on developing new therapeutic approaches. Learn more during #KidneyCancerAwarenessMonth: bit.ly/3NsnwHJ

Video teaser from the latest Behind the Breakthroughs episode. Host @GrinsteinJ speaks with Alicia Zhou, PhD, CEO of @CancerResearch, about CRI’s Discovery Engine and tumor–immune maps can add to cancer immunotherapy translation. hubs.li/Q045XhWl0 hubs.li/Q045XnVx0

How could federal funding cuts affect advances in cancer research, and influence young researchers to leave the field? CRI's CEO, Dr. Alicia Zhou, discusses the real-world impact today, and its implications on future innovation with @PNS_News: bit.ly/4bnpa6y #FundingCuts

More than half of early onset colorectal cancers have been linked to non-genetic risk factors such as smoking, high alcohol intake and physical inactivity, @thehill describes. Understand how early detection and lifestyle shifts could help lower #CRC rates: bit.ly/3OZbUMF

"If we want AI to accelerate cures, we first have to build the right foundation of data for it to train on," emphasizes CRI's CEO, Dr. Alicia Zhou. Understand how the CRI Discovery Engine will act as a living resource to unlock cancer's complexities @wef: bit.ly/4bq5crN

A moment from the latest Behind the Breakthroughs episode. Host @GrinsteinJ speaks with Alicia Zhou, PhD, on @CancerResearch’s Discovery Engine and how open tumor-immune interaction maps can strengthen cancer immunotherapy translation. Listen: hubs.li/Q045F5Pl0 @ay_zhou

Researchers from @MassGenBrigham and @DanaFarber, including Mike Goguen Immuno-Informatics Postdoctoral Fellow Dr. Maxime Meylan, report that a single dose of an oncolytic virus can help the immune system gain access to aggressive brain tumors. More: bit.ly/4r96CLW

Today, @CancerGrand has announced 5 new world-class teams that will come together to think differently and take on some of cancer’s toughest challenges. Discover ⤵️ #CancerGrandChallenges

Cancer survival rates have reached a historic high — 70% — but experts like @CancerResearch say uncertainty in research funding is already forcing labs to cut staff and pause projects. More than 18,000 Mississippians are expected to be diagnosed this year: buff.ly/nVqHIho